Disease/Infection News

RSS

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

The Global Coalition for Adaptive Research (GCAR) in collaboration with the University of Pittsburgh and UPMC, on behalf of the REMAP-CAP Investigator Network, announce clinical trial results examining the use of vitamin C and simvastatin to treat severely ill patients with COVID-19.

25 Oct 2023

COVID-19 mortality risk higher for people with severe mental illness, study shows

New research from King's College London has found that in the UK people with severe mental illness were at increased risk of death from all causes following COVID-19 infection compared to those without severe mental illness.

25 Oct 2023

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

The effects of vaccine booster doses on the adaptive evolution of the virus.

25 Oct 2023

Epidemic: What good is a vaccine when there is no rice?

The 1970s was the deadliest decade in the "entire history of Bangladesh," said environmental historian Iftekhar Iqbal

24 Oct 2023

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Study investigates the receptor affinity and antigenicity of the SARS-CoV-2 Omicron BA.2.86 variant, revealing that it does not show higher resistance to neutralization by human sera than other recent variants. Despite its high number of mutations and receptor affinity, the variant is slightly more sensitive to neutralization than the EG.5.1 variant, warranting continued surveillance.

24 Oct 2023

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Study found that the median duration of infectivity for the Omicron variant of SARS-CoV-2 in children is three days, regardless of vaccination status. The findings suggest that current 5-day isolation policies are supported, but vaccination or booster status need not be considered in return-to-school guidelines.

24 Oct 2023

Community immunity: Steering the evolutionary course of SARS-CoV-2

Researchers in Germany have developed a comprehensive fitness model that forecasts the evolution of SARS-CoV-2 by integrating genetic, epidemiological, and immunological data. The study emphasizes the role of population immunity in shaping viral mutations and provides valuable insights into the emergence of new variants.

24 Oct 2023

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

A recent study in the "Journal of Clinical Medicine" explored the long-term effects on sleep and circadian rhythms in COVID-19 survivors who experienced acute respiratory distress syndrome (ARDS). Findings revealed that a year after hospital discharge, over 91% of these patients suffered poor sleep quality, with nearly 59% experiencing insomnia, highlighting the lasting impact of COVID-19 on sleep health.

24 Oct 2023

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Data on the viral rebound and safety of nirmatrelvir/ritonavir in lung transplant (LTx) recipients are limited.

24 Oct 2023

Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice

This study aimed to improve the effectiveness of the rabies vaccine to help alleviate and eliminate the rabies epidemic.

24 Oct 2023

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

At the height of the COVID-19 pandemic, Virginia Tech disease ecologists wondered if the virus was having the same effect on wildlife.

24 Oct 2023

New consortium to build on breakthroughs in malaria research to develop P. vivax vaccines

Plasmodium vivax is the most widespread human malaria-causing pathogen with 2.5 billion people living at risk in Africa, South America, Oceania, and Asia.

24 Oct 2023

Research suggests shorter isolation periods for children with COVID-19

School policies that require students with COVID-19 to stay out of the classroom for five days are more than sufficient.

24 Oct 2023

Weakened innate immunity may increase risk of severe COVID-19

During severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activated macrophages, dendritic cells, neutrophils, and natural killer cells are the first defense against infection.

24 Oct 2023

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Certain gut-dwelling fungi flourish in severe cases of COVID-19, amplifying the excessive inflammation that drives this disease while also causing long-lasting changes in the immune system, according to a new study led by investigators at Weill Cornell Medicine and NewYork-Presbyterian.

24 Oct 2023

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Previous
1
...
94
95
96
97
98
99
100
...
2438
Next

Disease/Infection News

Global clinical trial provides new evidence on simvastatin and vitamin C for COVID-19

COVID-19 mortality risk higher for people with severe mental illness, study shows

Omicron's edge: boosters pressure SARS-CoV-2 to adapt and evolve

Epidemic: What good is a vaccine when there is no rice?

BA.2.86 Omicron sub-variant shows high receptor affinity but moderate neutralization resistance

Kids with Omicron non-infectious after three days, vaccination status irrelevant

Community immunity: Steering the evolutionary course of SARS-CoV-2

COVID-19 survivors face sleep battles, with ARDS patients hardest hit, study finds

Viral rebound common in lung transplant recipients treated with nirmatrelvir/ritonavir for COVID-19

Recombinant rabies virus vaccine with molecular adjuvant induces strong immune responses and protection in mice

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

New consortium to build on breakthroughs in malaria research to develop P. vivax vaccines

Research suggests shorter isolation periods for children with COVID-19

Weakened innate immunity may increase risk of severe COVID-19

Study sheds light on role of gut fungi in severe COVID-19 and long COVID

Study reveals impact of hybrid immunity and booster vaccination on antibody waning

Genomic surveillance could help detect and slow the spread of deadly 'superbugs'

AI-powered ECG tool supports the detection of heart disease

University of Montana awarded $12.3 million contract to develop novel vaccine adjuvant for TB vaccine

Deep-learning models predict COVID-19 cases globally with high accuracy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News